• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Media Articles

Explore insightful coverage and perspectives on Syngene from various media outlets.
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment
22nd Apr, 2025
Antibody-drug conjugates are a significant evolution in drug development landscape: Dr. Kenneth Barr
13th Apr, 2025
PROTACs: Current Landscape and Their Significance in Drug Discovery
27th Mar, 2025
Shaping the Future of Science Through Women Leaders in India
11th Mar, 2025
BW-healthcareworld_Logo
From The Lab To Leadership: Nurturing The Next Generation Of Women Scientists
10th Mar, 2025
Breaking Barriers, Driving Innovation and Shaping the Future
9th Mar, 2025

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details